Limitations of the PRODIGE 7 trial

Given that 13 (45%) of 29 patients in the cytoreductive surgery plus HIPEC group for whom data were available and 11 (39%) of 28 patients in the cytoreductive group discontinued neoadjuvant chemotherapy because of toxic effects, perhaps this strategy is not suitable for all patients. Patients with a...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The lancet oncology 2021-05, Vol.22 (5), p.e175-e175
Hauptverfasser:	Bhatt, Aditi, Mehta, Sanket, Kammar, Praveen, Saklani, Avanish
Format:	Artikel
Sprache:	eng
Schlagworte:	Chemotherapy Colorectal Neoplasms - drug therapy Cytoreduction Surgical Procedures Humans Hyperthermic Intraperitoneal Chemotherapy Leucovorin - therapeutic use Metastases Metastasis Peritoneal Neoplasms Peritoneum Surgery Survival Toxicity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!